ING Belgium
5
6M
5
0.06
1
1
- Areas of investment
Summary
In 1935 was created ING Belgium, which is appeared as Corporate Investor. The company was established in Europe in Belgium. The main office of represented Corporate Investor is situated in the Brussels.
The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 1 - 5 millions dollars. Speaking about the real fund results, this Corporate Investor is 30 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2009. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2015. Comparing to the other companies, this ING Belgium performs on 4 percentage points less the average number of lead investments.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the ING Belgium, startups are often financed by Capital-E, iMinds Ventures, PMV. The meaningful sponsors for the fund in investment in the same round are Vinnof, Riverside Company, NIBC Bank N.V.. In the next rounds fund is usually obtained by btov Partners, PMV.
Among the most popular portfolio startups of the fund, we may highlight CMOSIS nv. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most successful fund investment fields, there are Fashion, Biometrics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 1
- Exits
- 1
- Rounds per year
- 0.06
- Investments by industry
- Health Care (2)
- Artificial Intelligence (1)
- Hospital (1)
- Pharmaceutical (1)
- Industrial (1) Show 10 more
- Investments by region
-
- Belgium (5)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 0.60
- Avg. company exit year
- 8
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
LynxCare | 08 Apr 2019 | Artificial Intelligence, Health Care, Hospital | Seed | 2M | Flemish Brabant, Leuven, Belgium |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.